Literature DB >> 25725285

Cytoskeletal rearrangement and Src and PI-3K-dependent Akt activation control GABA(B)R-mediated chemotaxis.

Madhavi J Rane1, Jon B Klein1,2, Michelle T Barati1, Janice Scherzer1, Rui Wu1.   

Abstract

The γ-amino butyric acid (GABA) type B receptors (GABA(B)R) function as chemoattractant receptors in response to GABA(B)R agonists in human neutrophils. The goal of this study was to define signaling mechanisms regulating GABA(B)R-mediated chemotaxis and cytoskeletal rearrangement. In a proteomic study we identified serine/threonine kinase Akt, tyrosine kinases Src and Pyk2, microtubule regulator kinesin and microtubule affinity-regulating kinase (MARK) co-immunoprecipitating with GABA(B)R. To define the contributions of these candidate signaling events in GABA(B)R-mediated chemotaxis, we used rat basophilic leukemic cells (RBL-2H3 cells) stably transfected with human GABA(B1b) and GABA(B2) receptors. The GABA(B)R agonist baclofen induced Akt phosphorylation and chemotaxis by binding to its specific GABA(B)R since pretreatment of cells with CGP52432, a GABA(B)R antagonist, blocked such effects. Moreover, baclofen induced Akt phosphorylation was shown to be dependent upon PI-3K and Src kinases. Baclofen failed to stimulate actin polymerization in suspended RBL cells unless exposed to a baclofen gradient. However, baclofen stimulated both actin and tubulin polymerization in adherent RBL-GABA(B)R cells. Blockade of actin and tubulin polymerization by treatment of cells with cytochalasin D or nocodazole respectively, abolished baclofen-mediated chemotaxis. Furthermore, baclofen stimulated Pyk2 and STAT3 phosphorylation, both known regulators of cell migration. In conclusion, GABA(B)R stimulation promotes chemotaxis in RBL cells which is dependent on signaling via PI3-K/Akt, Src kinases and on rearrangement of both microtubules and actin cytoskeleton. These data define mechanisms of GABA(B)R-mediated chemotaxis which may potentially be used to therapeutically regulate cellular response to injury and disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akt; Baclofen; Chemotaxis; GABA(B) receptor; Microtubules; Src

Mesh:

Substances:

Year:  2015        PMID: 25725285      PMCID: PMC4381546          DOI: 10.1016/j.cellsig.2015.02.022

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  41 in total

Review 1.  Heterodimerization of the GABAB receptor-implications for GPCR signaling and drug discovery.

Authors:  Fiona H Marshall; Steven M Foord
Journal:  Adv Pharmacol       Date:  2010

Review 2.  Getting to the site of inflammation: the leukocyte adhesion cascade updated.

Authors:  Klaus Ley; Carlo Laudanna; Myron I Cybulsky; Sussan Nourshargh
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

Review 3.  Regulation of phagocyte migration and recruitment by Src-family kinases.

Authors:  A Baruzzi; E Caveggion; G Berton
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

4.  Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells.

Authors:  Michihisa Jougasaki; Tomoko Ichiki; Yoko Takenoshita; Manabu Setoguchi
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

5.  Role of different protein tyrosine kinases in fMLP-induced neutrophil transmigration.

Authors:  Ke Zen; Yuan Liu
Journal:  Immunobiology       Date:  2007-09-10       Impact factor: 3.144

Review 6.  Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay.

Authors:  George Z Cheng; Weizhou Zhang; Lu-Hai Wang
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

7.  GABAB receptor activation protects neurons from apoptosis via IGF-1 receptor transactivation.

Authors:  Haijun Tu; Chanjuan Xu; Wenhua Zhang; Qiuyao Liu; Philippe Rondard; Jean-Philippe Pin; Jianfeng Liu
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

8.  Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts.

Authors:  Angela Bruzzaniti; Lynn Neff; Amanda Sandoval; Liping Du; William C Horne; Roland Baron
Journal:  Mol Cell Biol       Date:  2009-04-20       Impact factor: 4.272

9.  Myeloid-specific deletion of tumor suppressor PTEN augments neutrophil transendothelial migration during inflammation.

Authors:  Bara Sarraj; Steffen Massberg; Yitang Li; Anongnard Kasorn; Kulandayan Subramanian; Fabien Loison; Leslie E Silberstein; Ulrich von Andrian; Hongbo R Luo
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

10.  Nifedipine interferes with migration of vascular smooth muscle cells via inhibition of Pyk2-Src axis.

Authors:  Nwe Nwe Soe; Takafumi Ishida; Mari Ishida; Mariko Sawano; Keiko Abe; Narimasa Miho; Kazuaki Chayama; Yasuki Kihara; Masao Yoshizumi
Journal:  J Atheroscler Thromb       Date:  2009-06-25       Impact factor: 4.928

View more
  7 in total

1.  A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.

Authors:  Jing Wu; Shuye Liu; Zhijuan Fan; Lei Zhang; Yaqiong Tian; Rui Yang
Journal:  Tumour Biol       Date:  2016-01-05

2.  Staphylococcus aureus drives expansion of low-density neutrophils in diabetic mice.

Authors:  Taylor S Cohen; Virginia Takahashi; Jessica Bonnell; Andrey Tovchigrechko; Raghothama Chaerkady; Wen Yu; Omari Jones-Nelson; Young Lee; Rajiv Raja; Sonja Hess; C Kendall Stover; John J Worthington; Mark A Travis; Bret R Sellman
Journal:  J Clin Invest       Date:  2019-04-15       Impact factor: 14.808

Review 3.  Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.

Authors:  Chen Xue; Ganglei Li; Juan Lu; Lanjuan Li
Journal:  Signal Transduct Target Ther       Date:  2021-11-24

4.  Prolactin Promotes Breast Cancer Cell Migration through Actin Cytoskeleton Remodeling.

Authors:  Priscilla Ludovico da Silva; Vinicius Cestari do Amaral; Valentina Gabrielli; Maria Magdalena Montt Guevara; Paolo Mannella; Edmund Chada Baracat; Jose Maria Soares; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2015-12-17       Impact factor: 5.555

5.  Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.

Authors:  Hsueh-Chou Lai; Chun-Chieh Yeh; Long-Bin Jeng; Shang-Fen Huang; Pei-Ying Liao; Fu-Ju Lei; Wei-Chun Cheng; Cheng-Lung Hsu; Xiujun Cai; Chawnshang Chang; Wen-Lung Ma
Journal:  Oncotarget       Date:  2016-07-19

6.  Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.

Authors:  Floriana Morgillo; Carminia Maria Della Corte; Anna Diana; Concetta di Mauro; Vincenza Ciaramella; Giusi Barra; Valentina Belli; Elisena Franzese; Roberto Bianco; Evaristo Maiello; Ferdinando de Vita; Fortunato Ciardiello; Michele Orditura
Journal:  Oncotarget       Date:  2017-08-22

Review 7.  GABAergic signaling by cells of the immune system: more the rule than the exception.

Authors:  Amol K Bhandage; Antonio Barragan
Journal:  Cell Mol Life Sci       Date:  2021-06-21       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.